Rebecca A. Byam - 19 Aug 2021 Form 4/A - Amendment Insider Report for HCW Biologics Inc. (HCWB)

Role: Chief Financial Officer
Signature: /s/ Nicole Valdivieso, as Attorney-in-Fact for Rebecca A. Byam
Issuer symbol: HCWB
Transactions as of: 19 Aug 2021
Net transactions value: +$43,979
Form type: 4/A - Amendment
Filing time: 10 Sep 2021, 17:53:33 UTC
Date Of Original Report: 23 Aug 2021
Previous filing: 23 Jul 2021
Next filing: 10 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCWB	Common Stock	Purchase	$43,979	+10,000	+19%	$4.40	62,000	19 Aug 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The range of prices for the shares of Common Stock is from $4.17 to $4.68. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.

Remarks:

The purpose of this amendment to the Form 4 filed on August 23, 2021 is to add a footnote disclosing the range of the prices for the shares bought on that day.